With the emergence and long-term Impact of COVID-19, Global Hemostasis Diagnostics Market to reach USD 12.40 Billion by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Hemostasis Diagnostics Market is poised to raise up to USD 12.40 Billion by 2030. Hemostasis diagnostic devices help discover hemostatic disorders that cause excessive bleeding. During hemostasis, blood transforms from liquid to gelatinous. Hemostasis is a technique that the body uses after an injury to limit blood loss and cease blood flow. Following this, there are three further steps: vasoconstriction, platelet plug formation, and blood coagulation. Rising blood clotting diagnostic rates among patients, particularly those who are more prone to losing extra blood from the body after procedures, are important reasons driving market expansion. The growth in the incidence of many diseases such as cancer, diabetes, and neurological disorders, as well as the increase in the older population and lifestyle changes, drive the hemostasis diagnostics market. During the projected period, the worldwide hemostasis diagnostics market is expected to be driven by an increase in the prevalence of haemophilia.
Geographically, the Global Hemostasis Diagnostics market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the widespread use of powerful automated analyzers, the availability of a large patient pool, and the high frequency of blood clot illnesses, and supportive government initiatives. Asia Pacific is expected to grow significantly during the forecast period, the region’s rapid market rise can be ascribed to several government efforts aimed at improving health-care infrastructure. The market in the area is expected to grow significantly in comparison to other regions, owing to a change in the base of pharmaceutical businesses and clinical research industries from developed to emerging nations such as China and India.
The Global Hemostasis Diagnostics market is highly competitive owing to the presence of several key manufacturers such as Abbott, Thermo Fisher Scientific Inc., HORIBA Europe Holding, Medtronic, Technidyne Corporation, Grifols S.A, F. Hoffmann-La Roche Ltd., NIHON KOHDEN CORPORATION, Haemonetics Corporation and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Hemostasis Diagnostics Market is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2023-2030.
- In the Product Segment, Pont of Care Testing Systems, emerged out as the leading market segment in 2022.
- In the Test Type, Prothrombin Time (PT) Test emerged as the leading market segment in 2022.
- In the End Use, Diagnostic Centers emerged as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to availability of a large patient pool, and the high frequency of blood clot illnesses, and supportive government initiatives.
- Asia-Pacific is expected to grow at a higher rate followed by North America during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
Product:
- Laboratory Analyzers
- Point-of-Care Testing Systems
Test Type:
- Activated Partial Thromboplastin Time
- D Dimer Test
- Fibrinogen Test
- Prothrombin Time Test
- Activated Clotting Time
- Platelet Aggregation Test
End Use:
- Hospitals
- Diagnostic Centers
- Others
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporates big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone : +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
